APCIO 2019
6th Asia-Pacific Congress of Interventional Oncology (APCIO) 2019
KL, Malaysia
2 - 5 October 2019
The conference ended on 05 October 2019
Important Dates
Abstract Submission Deadline
15th May 2019
Final Abstract / Full Paper Deadline
15th May 2019
Abstract Acceptance Notification
30th June 2019
Early Bird Deadline
15th July 2019
About APCIO 2019
Themed “Interventional Therapy in Modern Oncology: Technological Integration Beyond Boundaries”, our delegates can take away knowledge on new and effective treatment technologies in various new interventional options. We invite our colleagues to share their work and research through free paper oral presentations and live e poster presentation sessions. Submit your abstracts today!
Topics
Cancer, Endocrinology, Genetics, Radiology, Interventional radiology, Oncology, HepatologyCall for Papers
All abstracts are to be submitted online. Final forms of presentation can be in any of the following format:-
- Oral presentation
- Live poster presentation
- E-poster presentation
- Video presentation
If you plan to submit for ORAL PRESENTATION / LIVE POSTER PRESENTATION / E-POSTER PRESENTATION, please follow the following steps.
- Prepare your abstract in the following format. Maximum number of words is 250 words.
- Oral and Poster Abstract submission button is inside your delegate login account.
- Complete the details requested under author information.
- Key in the written summary you have prepared.
- Ensure that all changes, corrections and proof-reading has been carried out before submission.
- Click submit.
- Upon submission, you will receive an acknowledgement email notifying you that your abstract has been received with your Abstract ID.
- Should you wish to edit your abstract, you may login and do so anytime before the abstract closing deadline.
- Once the abstract deadline has closed, no more changes will be allowed by the system.
Keep Up to Date with PaperCrowd
Sign up and follow your favorite conferences.
Add Admin
Add Website
Add Deadline
Add Deadline
← Back
Log In
← Back
Sign Up
Success! We've just sent you an email with your followers.